Skip to main content

Advertisement

SpringerLink
Log in

Not only for the risk of bone fracture

  • Editorial
  • Published:
Journal of Bone and Mineral Metabolism Aims and scope Submit manuscript

The Original Article was published on 18 February 2015

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wakasugi M, Kazama JJ, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Narita I (2013) Increased risk of hip fracture among Japanese hemodialysis patients. J Bone Min Metab 31:315–321

    Article  Google Scholar 

  2. Fukagawa M, Hamada Y, Nakanishi S, Tanaka M (2006) The kidney and bone metabolism: a nephrologist’s view. J Bone Min Metab 24:434–438

    Article  CAS  Google Scholar 

  3. Komaba H, Kakuta T, Fukagawa M (2011) Diseases of the parathyroid gland in chronic kidney disease. Clin Exp Nephrol 15:797–809

    Article  CAS  PubMed  Google Scholar 

  4. Iwasaki-Ishizuka Y, Yamato H, Nii-Kono T, Fujieda A, Uchida M, Hosokawa A, Motojima M, Kurokawa K, Fukagawa M (2005) Down-regulation of parathyroid hormone receptor gene expression and osteoblastic dysfunction associated with skeletal resistance to parathyroid hormone in a rat model of chronic renal failure with low turnover bone. Nephrol Dial Transpl 20:1904–1911

    Article  CAS  Google Scholar 

  5. Nii-Kono T, Iwasaki Y, Yamato H, Fukagawa M (2007) Indoxyl sulfate induced skeletal resistance to PTH in osteoblastic cells. Kidney Int 71:738–743

    Article  CAS  PubMed  Google Scholar 

  6. Tanaka H, Iwasaki Y, Yamato H, Mori Y, Komaba H, Watanabe H, Maruyama T, Fukagawa M (2013) P-Cresyl sulfate induces osteoblast dysfunction through activating JNK and p38 MAPK pathways. Bone 56:347–354

    Article  CAS  PubMed  Google Scholar 

  7. Jadoul M, Albert JM, Akiba T, Akizawa T, Arab L, Bragg-Gesham JL, Mason N, Prutz KG, Young EW, Pisoni (2006) Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the dialysis outcomes and practice patterns study. Kidney Int 70:1358–1366

    Article  CAS  PubMed  Google Scholar 

  8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 76:S1–S130

  9. Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T et al (2013) For the CKD-MBD guideline working group, Japanese Society for Dialysis Therapy: clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder (CKD-MBD). Ther Aphr Dial 17:247–288

    Article  Google Scholar 

  10. Iimori S, Mori Y, Akita W, Kuyama T, Takada S, Asai T, Kuwahara M, Sasaki S, Tsukamoto Y (2012) Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fractures in CKD stage 5D patients—a single-center cohort study. Nephrol Dial Transpl 27:345–351

    Article  CAS  Google Scholar 

  11. West SL, Lok CE, Langsetmo L, Chung AM, Szabo E, Pearce D, Fusaro M, Wald R, Weinstein J, Jamal SA (2015) Bone mineral density predicts fractures in chronic kidney disease. J Bone Miner Res. doi:10.1002/jbmr.2406

    PubMed  Google Scholar 

  12. Kazama JJ, Matsuo K, Iwasaki Y, Fukagawa M (2015) Chronic kidney disease and bone metabolism. J Bone Miner Metab. doi:10.1007/s00774-014-0639-x

  13. Iwasaki Y, Kazama JJ, Yamato H, Shimoda H, Fukagawa M (2013) Accumulated uremic toxins attenuate elastic bone mechanical properties in rats with chronic kidney disease. Bone 57:477–483

    Article  CAS  PubMed  Google Scholar 

  14. Kazama JJ, Iwasaki Y, Fukagawa M (2013) Uremic osteoporosis. Kidney Int Supple 3:29–33

    Article  Google Scholar 

  15. Yokoyama K, Taniguchi M, Fukagawa M (2013) A Japanese approach for CKD-MBD. Kidney Int Supple 3:34–39

    Article  Google Scholar 

  16. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey, (2008) FRAX and the assessment of fracture probability in men and women from UK. Osteoporos Int 19:385–397

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  17. Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Oden A, Johansson H, Kanis JA (2008) Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int 19:429–435

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  18. Jamal SA, West SL, Nickolas TL (2014) The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease. Osteoporos Int 25:71–76

    Article  CAS  PubMed  Google Scholar 

  19. Noylor KL, Leslie WD, Hodsman AB, Rush DN, Garg AX (2014) FRAX predicts fracture risk in the kidney transplant recipients. Transplant 97:940–945

    Article  Google Scholar 

  20. Hayashi T, Joki N, Tanaka Y, Iwasaki M, Kubo S, Asakawa T, Matsukane A, Takahashi Y, Imamura Y, Hirahata K, Hase H (2015) The FRAX as a predictor of mortality in Japanese incident hemodialysis patients: an observational, follow-up study. J Bone Mineral Metab. doi:10.1007/s00774-014-0631-5

  21. Moe S, Drüeke T, Cunningham J et al (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69:1945–1953

    Article  CAS  PubMed  Google Scholar 

  22. London GM, Marchais SJ, Guerin AP, Boutouyrie P, Metivier F, de Vernehoul MC (2008) Association of bone activity, calcium load, aortic stiffness, and calcification in ESRD. J Am Soc Nephrol 19:1827–1835

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435

    Article  CAS  PubMed  Google Scholar 

  24. Komaba H, Fukagawa M (2012) The role of FGF23 in CKD: with or without Klotho. Nature Rev Nephrol 8:484–490

    Article  CAS  Google Scholar 

  25. Isakova T, Wahl P, Vargas GS, Gutierez OM, Scialla J et al (2011) Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease. Kidney Int 79:1370–1378

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  26. Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, Wolf M (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med 359:584–592

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  27. Scialla JJ, Xie H, Rahman M, Anderson AH, Isakova T et al (2014) Chronic Renal Insufficiency Cohort (CRIC) study investigators fibroblast growth factor-23 and cardiovascular events in CKD. J Am Soc Nephrol 25:349–360

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121:4393–4408

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Andrukhova O, Slavic S, Smorodchenko A, Zeitz U, Shalhoub V, Lanske B, Pohl EE, Erben RG et al (2014) FGFwe regulates renal sodium handling and blood pressure. EMBO Mol Med 5:744–759

    Google Scholar 

  30. Coe LM, Madathil SV, Casu C, Lanske B, Rivella S, Sitara D (2014) FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis. J Biol Chem 289:9795–9810

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Endocrinology, and Metabolism, Tokai University School of Medicine, 143 Shimo-Kasuya, Isehara, 259-1193, Kanagawa, Japan

    Masafumi Fukagawa

Authors
  1. Masafumi Fukagawa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masafumi Fukagawa.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fukagawa, M. Not only for the risk of bone fracture. J Bone Miner Metab 33, 603–604 (2015). https://doi.org/10.1007/s00774-015-0661-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00774-015-0661-7

Keywords

Search

Navigation